| Course | NU676 PMHNP Diagnosis and Management Across the Lifespan Clinical II |
|---|---|
| Unit | Unit 3 |
| Paper type | Medication management note |
| Length | About 660 words, 5 pages double-spaced |
| Format | APA 7 student paper |
| School | Purdue University Global |
| Program | MSN |
| Updated | September 2026 |
Free sample paper for NU676 Unit 3
Four Time Zones and a Drifting Dose: A Medication Management Note for a 33-Year-Old Flight Attendant Taking Lisdexamfetamine for ADHD
[Student Name]
Purdue University Global
NU676: PMHNP Diagnosis and Management Across the Lifespan Clinical II
Unit 3 Medication Management Note
[Instructor Name]
[Date]
The patient is composite; doses, times and readings are bracketed.
Subjective
Ms. [J.], [33], flight attendant with ADHD, combined presentation, on lisdexamfetamine [40] mg daily for [ten] months with good benefit at home: she reports finishing paperwork, fewer lost items and better focus during safety briefings. She works [three to four] trips a month crossing up to [four] time zones.
Since her last visit she has noticed two problems on trips. First, she lies awake until [02:00] local time on the first two nights of a layover. Second, on some duty days she feels "flat and foggy" by mid-afternoon. When asked about timing, she explained that she takes her capsule "at breakfast," but on layovers breakfast has moved to [11:00 or 12:00] local time, and on flights home her dose sometimes falls in the evening by her home clock. She has not missed doses or taken extra. Appetite reduced on duty days; she eats one meal and snacks. No palpitations or chest pain. Mood stable.
Objective
Blood pressure [124/80], heart rate [84]. Weight [61] kg, down [1] kg since last visit. Adult ADHD self-report symptom score [23], unchanged from last visit. Sleep diary for the last trip: sleep onset [01:45] and [02:10] local time on nights one and two.
Assessment
ADHD with good response at home and two travel-related problems, both explained by dose timing.
1. Late-night sleep onset on layovers. A long-acting stimulant taken close to midday local time can still be active at bedtime, and crossing time zones already disrupts sleep by shifting the body's clock out of line with local time (Sack et al., 2007). Her insomnia is not a new side effect of the drug but of the time at which she now takes it.
2. Afternoon fog on some duty days. When the dose is taken late by her body clock, its effect may not cover the part of the day when she needs it most, and the evening doses on flights home extend the pattern into the next night.
Lisdexamfetamine was effective and generally well tolerated in a controlled trial in adults with ADHD, with insomnia and reduced appetite among the more common adverse effects (Adler et al., 2008). Stimulants remain the most effective medication class for adults with ADHD in network meta-analysis (Cortese et al., 2018), and her benefit at home supports continuing the same drug and dose.
Plan
1. Timing rule: take the capsule within [one] hour of waking for her working day, whatever the local time, and not later than [eight] hours before planned sleep. Rationale: anchors the dose to her own day rather than to local meal times.
2. Flights home: if she has not taken her dose within an hour of waking, skip it for that day rather than take it late. Rationale: a missed dose on a travel day is less harmful than a night of lost sleep.
3. Dose unchanged at [40] mg. Rationale: benefit at home and no change in symptom score; the problems are timing, not dose.
4. Appetite: a protein-containing breakfast before the dose and a planned evening meal on duty days. Rationale: weight down [1] kg.
5. Sleep on layovers: light exposure and sleep timing advice for jet lag, and a short written plan for eastbound and westbound trips. Rationale: time zone crossings contribute to the insomnia independently of the drug.
6. Recheck in [six] weeks with a sleep diary from one eastbound and one westbound trip.
Safety
She is aware that stimulant prescriptions must be carried in their original container when traveling and checked the rules for the countries on her routes. She knows not to adjust the dose herself.
References
Adler, L. A., Goodman, D. W., Kollins, S. H., Weisler, R. H., Krishnan, S., Zhang, Y., & Biederman, J. (2008). Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. The Journal of Clinical Psychiatry, 69(9), 1364-1373. https://doi.org/10.4088/JCP.v69n0903
Cortese, S., Adamo, N., Del Giovane, C., Mohr-Jensen, C., Hayes, A. J., Carucci, S., Atkinson, L. Z., Tessari, L., Banaschewski, T., Coghill, D., Hollis, C., Simonoff, E., Zuddas, A., Barbui, C., Purgato, M., Steinhausen, H.-C., Shokraneh, F., Xia, J., & Cipriani, A. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis. The Lancet Psychiatry, 5(9), 727-738. https://doi.org/10.1016/S2215-0366(18)30269-4
Sack, R. L., Auckley, D., Auger, R. R., Carskadon, M. A., Wright, K. P., Jr., Vitiello, M. V., & Zhdanova, I. V. (2007). Circadian rhythm sleep disorders: Part I, basic principles, shift work and jet lag disorders. Sleep, 30(11), 1460-1483. https://doi.org/10.1093/sleep/30.11.1460
NU676 Unit 3 instructions, in plain terms
In Unit 3 you write a medication management note for a patient on a psychotropic you are adjusting or maintaining. The note usually records response to treatment with a rating, side effects asked about by name, vital signs, adherence and timing, an assessment of what is working and what is not, and a plan in which every change carries its reason. One to two pages is the usual length. What distinguishes a strong note is the link between each finding and each plan item; a change made without a stated reason leaves the next prescriber guessing. Notes that notice how the patient actually takes the medicine, not only whether she takes it, often find the explanation others miss.
How the NU 676 Unit 3 example is put together
The subjective section records her benefit at home, then the two travel problems and her explanation of when she takes the capsule on layovers and flights home. The objective section gives vital signs, weight, a symptom score and a two-night sleep diary. The assessment traces each problem to timing, citing the circadian rhythm review on time zone crossings and the lisdexamfetamine trial in adults, with a highlighted sentence on the real cause of the insomnia. Stimulant efficacy is supported with the network meta-analysis. Six plan items each end with a rationale, from a timing rule to jet lag advice, and a safety section covers carrying the prescription abroad.
NU676 Unit 3 rubric: what earns full points
Medication management notes in this course are generally graded on documentation of response, side effect assessment, the link between findings and plan, safety and clarity. Response earns full credit with a rating compared to the previous visit. Side effect assessment rewards specific effects asked about and measured, such as sleep onset and weight. The link row is the most heavily weighted in most rubrics and asks whether each plan item states the finding it responds to. Safety covers cardiovascular checks and, here, travel with a controlled substance. Clarity points go to notes a covering clinician could act on quickly without calling the author, which is the real test of any medication note.
NU676 Unit 3 help: mistakes that cost points
The most common error in stimulant notes is raising or lowering the dose when the problem is timing. Another is recording "no side effects" without asking about sleep, appetite and heart rate by name. Students often miss how shift work or travel changes when a dose is taken. Some notes change several things at once without explaining which finding drove which change. Others skip vital signs because the patient feels well. And a plan that tells a traveling patient only to "take as directed" gives her nothing to follow when her day starts at a different hour in a different country each week.
Get an NU676 Unit 3 example written to your instructions
Medication visit templates vary by site, so paste the one NU676 uses for Unit 3 with the rubric and a de-identified account of the visit, including which findings changed. A free first note returns in 24-48h for a composite patient, every plan line closing with the finding that justifies it, and the monitoring check recorded as a result. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
More NU676 papers and MSN samples
- NU676 Unit 1: RIME Rotation Objectives
- NU676 Unit 2: SNAPPS Presentation, Bupropion Insomnia
- NU676 Unit 4: Side Effect Review
- NU676 Unit 5: Feedback Reflection
- NU676 Unit 6: Case Conference Summary
- NU676 Unit 7: Journal Club Appraisal
- NU676 Unit 8: Discussion Board Post
- NU676 Unit 9: Serial Visit Note Set
- NU676 Unit 10: Defended Recommendation
- NU675 Unit 3: Valproate to Lamotrigine Switch Plan
- NU674 Unit 3: HPI With a Seasonal Pattern
- MN501 Unit 3: Scope of Practice Review
- NU673 Unit 3: Kratom Screening Write-Up
NU676 Unit 3 questions, answered
Why does every plan item need a because clause?
Because the next prescriber has to know why something changed, and the note is often all they have. A change with no stated reason cannot be continued, reversed or questioned sensibly. Short clauses pointing to findings already recorded keep the plan brief while making the reasoning visible, which is also what faculty grade in this unit.
What should a stimulant follow-up note document?
Commonly target symptoms with a rating, blood pressure, pulse, weight, sleep and appetite, adherence including any missed or extra doses, a check of the state prescription monitoring program where required, and any signs of misuse or diversion. Sites differ, and state rules on controlled-substance checks vary, so the note should follow the template and requirements the placement uses.
How is a medication management note different from a progress note?
Overlap is large, but a medication management note centers on the prescribing decision: response to the drug, adverse effects, adherence, relevant vitals or labs, and what happens to the regimen. A general progress note may give more room to therapy content or psychosocial events. Many sites combine the two, and the template determines which sections carry the most weight.
Where can I find a free NU676 Unit 3 sample paper?
This page holds the full NU676 Unit 3 medication management note, with the travel history, objective findings, an assessment tracing both problems to dose timing and six plan items with reasons, backed by three references. Share your own patient's regimen and a note can be built the same way.
Why is the dose not changed in NU676 Unit 3?
Her benefit at home and her symptom score are unchanged, so the problems on trips point to timing rather than dose. Anchoring the capsule to her waking time and skipping late doses on flights home addresses the cause directly.